Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 8901 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

Press Release: Japan first in the world to approve Dupixent® for chronic spontaneous urticaria (CSU)

Read more ››
By: GlobeNewswire - 16 Feb 2024
Related companies:  Sanofi SA

Global Cardiac Ablation Strategic Research Report 2024: Technological Advancements Broaden Adoption of Cardiac Ablation Technology - Forecasts to 2030

Read more ››
By: PR Newswire Association LLC. - 16 Feb 2024

Kanazawa University research: Chromatin Accessibility: A new avenue for gene editing

Read more ››
By: PR Newswire Association LLC. - 16 Feb 2024

Sosei Group: Notice of Change of Corporate Name to Nxera Pharma and Change of Location of Head Office

Read more ››
By: GlobeNewswire - 16 Feb 2024
Related companies:  Nxera Pharma Co., Ltd.

EFFECTS OF ARGENTINA HYPERINFLATIONARY ACCOUNTING ON Q4 AND FULL YEAR 2023 RESULTS

Read more ››
By: PR Newswire Association LLC. - 16 Feb 2024

PADCEV™ (enfortumab vedotin (genetical recombination)) with KEYTRUDA® (pembrolizumab (genetical recombination)) Granted Priority Review by Japan's Ministry of Health, Labour and Welfare for First-Line Treatment of Advanced Bladder Cancer

Read more ››
By: PR Newswire Association LLC. - 16 Feb 2024
Related companies:  Astellas Pharma Inc.

Astellas and Kelonia Therapeutics Enter into Research and License Agreement to Develop Novel Immuno-Oncology Therapeutics

Read more ››
By: PR Newswire Association LLC. - 16 Feb 2024

Greenberg Traurig Grows FDA Practice in Phoenix; Adds Peter Arhangelsky

Read more ››
By: PR Newswire Association LLC. - 16 Feb 2024

Paclitaxel Injection Global Market Report 2024 - Paclitaxel Injection Market to Reach $9.85 Billion by 2028

Read more ››
By: PR Newswire Association LLC. - 16 Feb 2024

Beacon Behavioral Partners Celebrates Expansion Across the Southeast United States

Read more ››
By: GlobeNewswire - 15 Feb 2024

Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides a Corporate Update

Read more ››
By: GlobeNewswire - 15 Feb 2024
Related companies:  Nurix Therapeutics, Inc.

Travere Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

Read more ››
By: GlobeNewswire - 15 Feb 2024
Related companies:  Travere Therapeutics, Inc.

Galapagos presents at EBMT-EHA annual meeting 2024

Read more ››
By: GlobeNewswire - 15 Feb 2024
Related companies:  Galapagos NV

Ultragenyx Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update

Read more ››
By: GlobeNewswire - 15 Feb 2024
Related companies:  Ultragenyx Pharmaceutical Inc.

Taysha Gene Therapies Provides Update on Deprioritized Pipeline Programs

Read more ››
By: GlobeNewswire - 15 Feb 2024
Related companies:  Taysha Gene Therapies, Inc.

Corcept Announces Preliminary Results From Prevalence Phase Of CATALYST Clinical Trial

Read more ››
By: GlobeNewswire - 15 Feb 2024
Related companies:  Corcept Therapeutics Incorporated

T2 Biosystems Announces Commercial Expansion Through Distributors in Europe and Asia

Read more ››
By: GlobeNewswire - 15 Feb 2024
Related companies:  T2 Biosystems, Inc.

Shockwave Medical Reports Fourth Quarter and Full Year 2023 Financial Results

Read more ››
By: GlobeNewswire - 15 Feb 2024
Related companies:  Shockwave Medical, Inc.

T2 Biosystems Announces Agreement with CRG for the Conversion of $15 Million of CRG Term Loan into Equity

Read more ››
By: GlobeNewswire - 15 Feb 2024
Related companies:  T2 Biosystems, Inc.

Prelude Therapeutics Reports Full Year 2023 Financial Results and Outlines Key Objectives for 2024

Read more ››
By: GlobeNewswire - 15 Feb 2024
Related companies:  Prolight Diagnostics AB | Prelude Therapeutics Incorporated
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑